Mark Krause
Directeur des opérations chez Evolve Biologics, Inc.
Profil
Mark Krause has worked as a Director of Product Management at Cedarapids, Inc. in the past.
Currently, he holds the position of Senior Vice President of Operations at Evolve Biologics, Inc.
Postes actifs de Mark Krause
| Sociétés | Poste | Début |
|---|---|---|
Cedarapids, Inc.
 Cedarapids, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Cedarapids, Inc. manufactures road construction equipment. It also manufactures crushing & screening, asphalt paving, and recycling products. The company was founded in 1923 and is headquartered in Cedar Rapids, IA. | Corporate Officer/Principal | - |
Evolve Biologics, Inc.
 Evolve Biologics, Inc. Pharmaceuticals: MajorHealth Technology Evolve Biologics, Inc. is a Canadian plasma-derived therapeutics company headquartered in Mississauga, CA. The company is focused on commercializing a portfolio of product candidates, including intravenous immunoglobulin (IVIG) and human serum albumin (HSA), both of which are in advanced stages of regulatory approval with the FDA and Health Canada. Evolve's state-of-the-art facility is the first to use its innovative and proprietary technology, Plasmacap EBA®, to commercially produce plasma-derived therapeutics. The company has recently appointed James V. Caggiano as CEO, who brings nearly 30 years of experience in the biotech, pharma, and medical device industries. | Directeur des opérations | 01/01/2021 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Cedarapids, Inc.
Cedarapids, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Cedarapids, Inc. manufactures road construction equipment. It also manufactures crushing & screening, asphalt paving, and recycling products. The company was founded in 1923 and is headquartered in Cedar Rapids, IA. | Producer Manufacturing |
Evolve Biologics, Inc.
Evolve Biologics, Inc. Pharmaceuticals: MajorHealth Technology Evolve Biologics, Inc. is a Canadian plasma-derived therapeutics company headquartered in Mississauga, CA. The company is focused on commercializing a portfolio of product candidates, including intravenous immunoglobulin (IVIG) and human serum albumin (HSA), both of which are in advanced stages of regulatory approval with the FDA and Health Canada. Evolve's state-of-the-art facility is the first to use its innovative and proprietary technology, Plasmacap EBA®, to commercially produce plasma-derived therapeutics. The company has recently appointed James V. Caggiano as CEO, who brings nearly 30 years of experience in the biotech, pharma, and medical device industries. | Health Technology |
